Webinar: Clinical Trials - Information To Help You Plan Your Next Steps - POCTRN
Center news
Webinar: Clinical Trials - Information To Help You Plan Your Next Steps
Clinical Trials are a critically important, yet complex, step toward bringing important point of care technologies to the patients who need them. Join us for our webinar when our speaker will discuss strategies that will help you plan your next steps.
Speakers
Erin Iturriaga, DNP, MSN, RN
Program Officer/Clinical Trials Specialist
National Heart, Lung, and Blood Institute (NHLBI)
Chris Sasiela, PhD, RAC
Regulatory Specialist
National Heart, Lung, and Blood Institute (NHLBI)
When
This webinar took place Wednesday, October 30, 2019
This webinar is designed by the NIH Point of Care Technology Research Network (POCTRN) to provide relevant information to stakeholders interested in point-of-care technology research and development. POCTRN's goal is to develop technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.

RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness